細胞・遺伝子治療臨床試験サービスの世界市場レポート 2025年

細胞・遺伝子治療臨床試験サービス市場規模は、今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は10.3％で、62億2,000万米ドルに成長します。予測期間における成長の背景には、遺伝性疾患や自己免疫疾患の世界の罹患率の増加、遺伝子治療研究に対する公的・民間部門の資金提供の増加、新規技術の採用拡大、遺伝子異常の増加などがあります。予測期間における主な動向には、AIの採用、機械学習の採用、個別化医療の採用、技術の進歩、遺伝子治療などがあります。

遺伝性疾患の有病率の増加は、今後の細胞・遺伝子治療臨床試験サービス市場の拡大を促進すると予想されます。遺伝性疾患は、個人のDNAや遺伝的構造の変異に起因するものであり、遺伝子検査へのアクセスの向上、遺伝子変異の発生、近親婚の普及などの要因により、一般的になりつつあります。細胞・遺伝子治療臨床試験サービスは、革新的な治療法の開発を促進し、個々の患者のために治療法をカスタマイズし、研究の臨床応用への転換を加速し、遺伝性疾患患者が利用できる治療法の選択肢を広げることによって、増加する遺伝性疾患の発生率に対処する上で重要な役割を果たしています。例えば、嚢胞性線維症（CF）財団の2022年7月の報告書によると、嚢胞性線維症と診断される患者数は顕著に増加しており、米国だけでも約4万人の子供と成人が罹患しています。その結果、遺伝性疾患の有病率の上昇が細胞・遺伝子治療臨床試験サービス市場成長の主要促進要因となっています。

細胞・遺伝子治療臨床試験サービス市場の主要企業は、顧客関係管理（CRM）システム技術などの先進技術の導入に力を注ぎ、業務効率を高めて競争上の優位性を獲得しています。細胞・遺伝子治療臨床試験サービスが活用するCRMシステムは、臨床試験のプロセスを通じて、臨床試験参加者やヘルスケアプロバイダー、その他の利害関係者とのやり取りを合理化・管理します。例えば、2023年 4月、AmerisourceBergen Corporationは、細胞・遺伝子治療パスウェイ全体の接続性を強化し、プロセスを合理化するために設計されたプラットフォーム、Cell and Gene Therapy（CGT）Integration Hubを発表しました。アメリソース・バーゲンのCRMシステムによって開発されたこのプラットフォームは、医師や患者サービスチームが治療法の開発から提供までのプロセス全体をよりよく把握できるようにすることで、ケアコーディネーションを簡素化することを目的としています。CGT Integration Hubには、迅速な給付金調査、リアルタイムのステータス追跡、プロアクティブアラートなどの機能が含まれており、これらはすべて、ケアコーディネーションを簡素化し、細胞および遺伝子治療の提供における患者と医療提供者の全体的な経験を向上させることを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界細胞・遺伝子治療臨床試験サービス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の細胞・遺伝子治療臨床試験サービス市場：成長率分析
• 世界の細胞・遺伝子治療臨床試験サービス市場の実績：規模と成長, 2019-2024
• 世界の細胞・遺伝子治療臨床試験サービス市場の予測：規模と成長, 2024-2029, 2034F
• 世界細胞・遺伝子治療臨床試験サービス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の細胞・遺伝子治療臨床試験サービス市場：サービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 臨床試験の設計と計画
• 供給および物流サービス
• 規制業務およびコンプライアンス
• データ管理と生物統計学
• サイト管理と監視
• その他のサービス
• 世界の細胞・遺伝子治療臨床試験サービス市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 遺伝子治療
• 細胞療法
• 遺伝子改変細胞療法
• 世界の細胞・遺伝子治療臨床試験サービス市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 血液学
• 代謝障害
• 感染症
• 神経学
• 心血管疾患
• 筋骨格系障害
• その他の適応症
• 世界の細胞・遺伝子治療臨床試験サービス市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬およびバイオテクノロジー企業
• 契約調査機関
• 学術研究機関
• その他のエンドユーザー
• 世界の細胞・遺伝子治療臨床試験サービス市場臨床試験の設計と計画の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• プロトコル開発
• 試験実現可能性調査
• 試験設計に関する相談
• 患者募集と登録戦略
• リスクベースのモニタリング計画
• 世界の細胞・遺伝子治療臨床試験サービス市場供給および物流サービスのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 臨床試験サプライチェーン管理
• コールドチェーン物流
• 包装およびラベルサービス
• 生物学的サンプルの輸送と配送
• 通関および輸出入サービス
• 世界の細胞・遺伝子治療臨床試験サービス市場、規制業務およびコンプライアンスのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 規制戦略とコンサルティング
• 規制当局への提出と文書
• GMP（適正製造規範）への準拠
• 規制経路に関する協議
• 臨床試験申請（CTA）
• 世界の細胞・遺伝子治療臨床試験サービス市場データ管理と生物統計学のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 臨床データ管理（CDM）
• 統計分析と報告
• 臨床データモニタリング
• データ統合と検証
• 電子データキャプチャ（EDC）ソリューション
• 世界の細胞・遺伝子治療臨床試験サービス市場サイト管理と監視の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• サイトの選択と開始
• 臨床モニタリングと現場訪問
• 患者の募集と維持
• 現場トレーニングとサポート
• サイトパフォーマンス監視
• 世界の細胞・遺伝子治療臨床試験サービス市場その他のサービスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 患者の擁護と関与
• リアルワールドエビデンス（RWE）研究
• 裁判後のサービス
• 医学的ライティングとドキュメンテーション
• 臨床試験の監査と検査

第7章 地域別・国別分析

• 世界の細胞・遺伝子治療臨床試験サービス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の細胞・遺伝子治療臨床試験サービス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 細胞・遺伝子治療臨床試験サービス市場：競合情勢
• 細胞・遺伝子治療臨床試験サービス市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sharp Services LLC Overview, Products and Services, Strategy and Financial Analysis
  • IQVIA Overview, Products and Services, Strategy and Financial Analysis
  • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • ICON plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Syneos Health Inc.
• Catalent Pharma Solutions Inc.
• Charles River Laboratories International Inc.
• Parexel International Corporation
• PRA Health Sciences Inc.
• Covance Inc.
• Medpace Holdings Inc.
• BioClinica Inc.
• Precision Medicine Group LLC
• Worldwide Clinical Trials LLC
• Clinigen Group plc
• Evidera Inc.
• Advarra LLC
• Veristat LLC
• Clinipace Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 細胞・遺伝子治療臨床試験サービス市場2029：新たな機会を提供する国
• 細胞・遺伝子治療臨床試験サービス市場2029：新たな機会を提供するセグメント
• 細胞・遺伝子治療臨床試験サービス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cell and gene therapy clinical trial services are specialized offerings provided by contract research organizations (CROs) or clinical trial management firms to support the design, implementation, and oversight of clinical trials for cell and gene therapies. These services encompass various aspects such as protocol design, patient recruitment, regulatory compliance, and data management, ensuring precision, efficacy, and adherence to rigorous standards throughout the trial process.

The primary types of cell and gene therapy clinical trial services include clinical trial design and planning, supply chain and logistics management, regulatory affairs and compliance, data management and biostatistics, site management and monitoring, among others. Clinical trial design and planning entail the development and organization of trial protocols, determining the objectives and methodologies of the trial. Various types of therapies, including gene therapy, cell therapy, and gene-modified cell therapy, are utilized for a range of indications such as oncology, hematology, metabolic disorders, infectious diseases, neurology, cardiovascular diseases, musculoskeletal disorders, among others. These services cater to a diverse range of end-users, including pharmaceutical and biotechnology companies, contract research organizations, academic and research institutions, among others.

The cell and gene therapy clinical trial services market research report is one of a series of new reports from The Business Research Company that provides cell and gene therapy clinical trial services market statistics, including cell and gene therapy clinical trial services industry global market size, regional shares, competitors with a cell and gene therapy clinical trial services market share, detailed cell and gene therapy clinical trial services market segments, market trends and opportunities, and any further data you may need to thrive in the cell and gene therapy clinical trial services industry. This cell and gene therapy clinical trial services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell and gene therapy clinical trial services market size has grown rapidly in recent years. It will grow from $3.79 billion in 2024 to $4.2 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to the increased prevalence of chronic diseases, increased demand for effective treatments for rare genetic disorders, increased government funding for research in regenerative medicine, increased understanding of molecular mechanisms underlying various diseases, and increased awareness of the potential of personalized medicine.

The cell and gene therapy clinical trial services market size is expected to see rapid growth in the next few years. It will grow to $6.22 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing global incidence of genetic and auto-immune diseases, rising public and private sector funding for gene therapy research, growing adoption of novel technologies, and a rise in the number of genetic defects. Major trends in the forecast period include the adoption of AI, the adoption of machine learning, the adoption of personalized medicine, technological advancements, and gene therapies.

The increasing prevalence of genetic diseases is expected to drive the expansion of the cell and gene therapy clinical trial services market in the future. Genetic diseases result from variations in an individual's DNA or genetic makeup and are becoming more common due to factors such as increased accessibility to genetic testing, occurrences of genetic mutations, and the prevalence of consanguineous marriages. Cell and gene therapy clinical trial services play a crucial role in addressing the growing incidence of genetic diseases by fostering the development of innovative treatments, customizing therapies for individual patients, accelerating the translation of research into clinical applications, and broadening the treatment options available to patients with genetic disorders. For instance, according to the Cystic Fibrosis (CF) Foundation's July 2022 report, there has been a notable increase in the number of individuals diagnosed with cystic fibrosis, affecting nearly 40,000 children and adults in the United States alone, and over 105,000 people worldwide. Consequently, the rising prevalence of genetic diseases is a key driver behind the growth of the cell and gene therapy clinical trial services market.

Leading companies in the cell and gene therapy clinical trial services market are concentrating their efforts on introducing advanced technology, including customer relationship management (CRM) system technology, to enhance operational efficiency and gain a competitive advantage. CRM systems utilized by cell and gene therapy clinical trial services streamline and manage interactions with trial participants, healthcare providers, and other stakeholders throughout the clinical trial process. For instance, in April 2023, AmerisourceBergen Corporation unveiled the Cell and Gene Therapy (CGT) Integration Hub, a platform designed to enhance connectivity and streamline processes across the cell and gene therapy treatment pathway. Supported by AmerisourceBergen's CRM system, this platform aims to simplify care coordination by providing physicians and patient services teams with better visibility throughout the therapy development and delivery process. The CGT Integration Hub includes features such as expedited benefits investigation, real-time status tracking, and proactive alerts, all aimed at simplifying care coordination and improving the overall patient and provider experience in delivering cell and gene therapies.

In January 2024, Kyowa Kirin Co. Ltd. acquired Orchard Therapeutics Limited to strengthen its focus on addressing unmet medical needs in genetic and severe diseases by leveraging Orchard's expertise in developing and commercializing gene therapies for rare diseases. Orchard Therapeutics Limited, a UK-based biotechnology company, is dedicated to researching, developing, and commercializing gene therapies for rare diseases.

Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.

North America was the largest region in the cell and gene therapy clinical trial services market in 2024. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell and gene therapy clinical trial services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell and gene therapy clinical trial services market includes revenues earned by providing services, such as regulatory pathways navigation, logistics management, patient retention strategy management, and biomarker analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell And Gene Therapy Clinical Trial Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell and gene therapy clinical trial services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell and gene therapy clinical trial services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell and gene therapy clinical trial services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Service: Clinical Trial Design And Planning; Supply And Logistic Services; Regulatory Affairs And Compliance; Data Management And Biostatics; Site Management And Monitoring; Other Services
• 2) By Therapy Type: Gene Therapy; Cell Therapy; Gene Modified Cell Therapy
• 3) By Indication: Oncology; Hematology; Metabolic Disorders; Infectious Diseases; Neurology; Cardiovascular Diseases; Musculoskeletal Disorders; Other Indications
• 4) By End-Use: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic And Research Institutes; Other End-Users
• Subsegments:
• 1) By Clinical Trial Design And Planning: Protocol Development; Trial Feasibility Studies; Trial Design Consultation; Patient Recruitment And Enrollment Strategy; Risk-Based Monitoring Plans
• 2) By Supply And Logistic Services: Clinical Trial Supply Chain Management; Cold Chain Logistics; Packaging And Labeling Services; Transportation And Distribution Of Biological Samples; Customs And Import/Export Services
• 3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting; Regulatory Submission And Documentation; Compliance With GMP (Good Manufacturing Practices); Regulatory Pathway Consultation; Clinical Trial Applications (CTAs)
• 4) By Data Management And Biostatistics: Clinical Data Management (CDM); Statistical Analysis And Reporting; Clinical Data Monitoring; Data Integration And Validation; Electronic Data Capture (EDC) Solutions
• 5) By Site Management And Monitoring: Site Selection And Initiation; Clinical Monitoring And Site Visits; Patient Recruitment And Retention; Site Training And Support; Site Performance Monitoring
• 6) By Other Services: Patient Advocacy And Engagement; Real-World Evidence (RWE) Studies; Post-Trial Services; Medical Writing And Documentation; Clinical Trial Auditing And Inspection
• Companies Mentioned: Thermo Fisher Scientific Inc.; Sharp Services LLC; IQVIA; Laboratory Corporation of America Holdings; ICON plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell And Gene Therapy Clinical Trial Services Market Characteristics

3. Cell And Gene Therapy Clinical Trial Services Market Trends And Strategies

4. Cell And Gene Therapy Clinical Trial Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cell And Gene Therapy Clinical Trial Services Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cell And Gene Therapy Clinical Trial Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cell And Gene Therapy Clinical Trial Services Market Growth Rate Analysis
• 5.4. Global Cell And Gene Therapy Clinical Trial Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cell And Gene Therapy Clinical Trial Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cell And Gene Therapy Clinical Trial Services Total Addressable Market (TAM)

6. Cell And Gene Therapy Clinical Trial Services Market Segmentation

• 6.1. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Trial Design And Planning
• Supply And Logistic Services
• Regulatory Affairs And Compliance
• Data Management And Biostatics
• Site Management And Monitoring
• Other Services
• 6.2. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Therapy
• Cell Therapy
• Gene Modified Cell Therapy
• 6.3. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Hematology
• Metabolic Disorders
• Infectious Diseases
• Neurology
• Cardiovascular Diseases
• Musculoskeletal Disorders
• Other Indications
• 6.4. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Contract Research Organizations
• Academic And Research Institutes
• Other End-Users
• 6.5. Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Clinical Trial Design And Planning, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Protocol Development
• Trial Feasibility Studies
• Trial Design Consultation
• Patient Recruitment And Enrollment Strategy
• Risk-Based Monitoring Plans
• 6.6. Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Supply And Logistic Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Trial Supply Chain Management
• Cold Chain Logistics
• Packaging And Labeling Services
• Transportation And Distribution Of Biological Samples
• Customs And Import/Export Services
• 6.7. Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Regulatory Affairs And Compliance, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Regulatory Strategy And Consulting
• Regulatory Submission And Documentation
• Compliance With GMP (Good Manufacturing Practices)
• Regulatory Pathway Consultation
• Clinical Trial Applications (CTAs)
• 6.8. Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Data Management And Biostatistics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Data Management (CDM)
• Statistical Analysis And Reporting
• Clinical Data Monitoring
• Data Integration And Validation
• Electronic Data Capture (EDC) Solutions
• 6.9. Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Site Management And Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Site Selection And Initiation
• Clinical Monitoring And Site Visits
• Patient Recruitment And Retention
• Site Training And Support
• Site Performance Monitoring
• 6.10. Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Patient Advocacy And Engagement
• Real-World Evidence (RWE) Studies
• Post-Trial Services
• Medical Writing And Documentation
• Clinical Trial Auditing And Inspection

7. Cell And Gene Therapy Clinical Trial Services Market Regional And Country Analysis

• 7.1. Global Cell And Gene Therapy Clinical Trial Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cell And Gene Therapy Clinical Trial Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market

• 8.1. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell And Gene Therapy Clinical Trial Services Market

• 9.1. China Cell And Gene Therapy Clinical Trial Services Market Overview
• 9.2. China Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell And Gene Therapy Clinical Trial Services Market

• 10.1. India Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell And Gene Therapy Clinical Trial Services Market

• 11.1. Japan Cell And Gene Therapy Clinical Trial Services Market Overview
• 11.2. Japan Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell And Gene Therapy Clinical Trial Services Market

• 12.1. Australia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell And Gene Therapy Clinical Trial Services Market

• 13.1. Indonesia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell And Gene Therapy Clinical Trial Services Market

• 14.1. South Korea Cell And Gene Therapy Clinical Trial Services Market Overview
• 14.2. South Korea Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell And Gene Therapy Clinical Trial Services Market

• 15.1. Western Europe Cell And Gene Therapy Clinical Trial Services Market Overview
• 15.2. Western Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell And Gene Therapy Clinical Trial Services Market

• 16.1. UK Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell And Gene Therapy Clinical Trial Services Market

• 17.1. Germany Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell And Gene Therapy Clinical Trial Services Market

• 18.1. France Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell And Gene Therapy Clinical Trial Services Market

• 19.1. Italy Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell And Gene Therapy Clinical Trial Services Market

• 20.1. Spain Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market

• 21.1. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market Overview
• 21.2. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell And Gene Therapy Clinical Trial Services Market

• 22.1. Russia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell And Gene Therapy Clinical Trial Services Market

• 23.1. North America Cell And Gene Therapy Clinical Trial Services Market Overview
• 23.2. North America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell And Gene Therapy Clinical Trial Services Market

• 24.1. USA Cell And Gene Therapy Clinical Trial Services Market Overview
• 24.2. USA Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell And Gene Therapy Clinical Trial Services Market

• 25.1. Canada Cell And Gene Therapy Clinical Trial Services Market Overview
• 25.2. Canada Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell And Gene Therapy Clinical Trial Services Market

• 26.1. South America Cell And Gene Therapy Clinical Trial Services Market Overview
• 26.2. South America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell And Gene Therapy Clinical Trial Services Market

• 27.1. Brazil Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell And Gene Therapy Clinical Trial Services Market

• 28.1. Middle East Cell And Gene Therapy Clinical Trial Services Market Overview
• 28.2. Middle East Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell And Gene Therapy Clinical Trial Services Market

• 29.1. Africa Cell And Gene Therapy Clinical Trial Services Market Overview
• 29.2. Africa Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell And Gene Therapy Clinical Trial Services Market Competitive Landscape And Company Profiles

• 30.1. Cell And Gene Therapy Clinical Trial Services Market Competitive Landscape
• 30.2. Cell And Gene Therapy Clinical Trial Services Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sharp Services LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. IQVIA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. ICON plc Overview, Products and Services, Strategy and Financial Analysis

31. Cell And Gene Therapy Clinical Trial Services Market Other Major And Innovative Companies

• 31.1. Syneos Health Inc.
• 31.2. Catalent Pharma Solutions Inc.
• 31.3. Charles River Laboratories International Inc.
• 31.4. Parexel International Corporation
• 31.5. PRA Health Sciences Inc.
• 31.6. Covance Inc.
• 31.7. Medpace Holdings Inc.
• 31.8. BioClinica Inc.
• 31.9. Precision Medicine Group LLC
• 31.10. Worldwide Clinical Trials LLC
• 31.11. Clinigen Group plc
• 31.12. Evidera Inc.
• 31.13. Advarra LLC
• 31.14. Veristat LLC
• 31.15. Clinipace Inc.

32. Global Cell And Gene Therapy Clinical Trial Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell And Gene Therapy Clinical Trial Services Market

34. Recent Developments In The Cell And Gene Therapy Clinical Trial Services Market

35. Cell And Gene Therapy Clinical Trial Services Market High Potential Countries, Segments and Strategies

• 35.1 Cell And Gene Therapy Clinical Trial Services Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cell And Gene Therapy Clinical Trial Services Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cell And Gene Therapy Clinical Trial Services Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer